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Abstract. 
 
Nuclear RNA transcription is repressed 
when eukaryotic cells enter mitosis. Here, we found 
that the derepression of ribosomal gene (rDNA) tran-
 
scription that normally takes place in telophase may 
be induced in prometaphase, metaphase, and anaphase 
mitotic HeLa cells, and therefore appears not to be 
dependent on completion of mitosis. We demonstrate 
for the ﬁrst time that in vivo inhibition of the cdc2–
cyclin B kinase activity is sufﬁcient to give rise to oka-
daic acid–sensitive dephosphorylation of the mitotically 
phosphorylated forms of components of the rDNA 
transcription machinery, and consequently to restore 
rDNA transcription in mitotic cells. These results, 
showing that during mitosis the rDNA transcription 
machinery is maintained repressed by the cdc2–cyclin B 
kinase activity, provide an in vivo demonstration of the 
cell cycle–dependent regulation of rDNA transcription. 
Interestingly in mitotic cells, the newly synthesized 47S 
precursor ribosomal RNA (pre-rRNA) is not processed 
into the mature rRNAs, indicating that rDNA tran-
scription and pre-rRNA processing may be uncoupled. 
 
Moreover this suggests that inhibition of the cdc2– 
cyclin B kinase is not sufﬁcient to activate the 47S 
pre-rRNA processing machinery and/or to induce its 
relocalization at the level of newly synthesized 47S pre-
rRNA. This in vivo approach provides new possibilities 
to investigate the correlation between pre-rRNA syn-
thesis and pre-rRNA processing when the nucleolus re-
forms.
Key words: ribosomal DNA transcription • cdc2–
 
cyclin B kinase • ribosomal RNA processing • rosco-
vitine • mitosis
 
Introduction
 
As higher eukaryote cells enter mitosis, transcription is re-
pressed. Silencing of ribosomal gene (rDNA)
 
1
 
 transcrip-
tion occurs from prophase (Prescott and Bender, 1962;
Gébrane-Younès et al., 1997) to telophase (Prescott and
Bender, 1962; Roussel et al., 1996; and for review see
Thiry and Goessens, 1996). This appears to be a general
feature, since only slight variability of this timing can be
observed depending on cells. Concurrently, precursor ri-
bosomal RNA (pre-rRNA) processing is arrested at the
entrance to and restored at the exit from mitosis (Fan and
Penman, 1971). The timing of these events suggests a link
with cell cycle controls that could be mediated by the
cdc2–cyclin B kinase pathway. Moreover, recent results
obtained in vitro have shown that mitotic silencing of
rDNA transcription is most probably due to cdc2–cyclin B
kinase–directed phosphorylation (Heix et al., 1998; Kuhn
et al., 1998), as reported previously for RNA polymerase
(RNA pol) II– and III–dependent transcription (for re-
view see Gottesfeld and Forbes, 1997). However, it re-
mains to be elucidated how mitotic cells maintain repres-
sion of rDNA transcription in vivo, how they activate
transcription at the end of mitosis, and in particular if this
activation may be induced in cells without completion of
mitosis. Moreover it would be interesting to know if re-
sumption of rDNA transcription gives rise to pre-rRNA
processing.
The rDNA transcription machinery remains assembled
during mitosis. The different complexes and factors (RNA
pol I, upstream binding factor [UBF], TATA-binding pro-
tein [TBP]-containing factor SL1) that are sufficient to
promote rDNA transcription in vitro (for review see Moss
 
Address correspondence to Danièle Hernandez-Verdun, Institut Jacques
Monod, 2 place Jussieu, 75251 Paris Cedex 05, France. Tel.: 331 44 27 40
38. Fax: 331 44 27 59 94. E-mail: dhernand@ccr.jussieu.fr
 
1
 
Abbreviations used in this paper: 
 
BrUTP, bromo-uridine 5
 
9
 
-triphos-
phate; DAPI, 4,6-diamidino-2-phenylindole; ETS, 5
 
9
 
-external transcribed
spacer; NOR, nucleolar organizer region; PP-1, protein phosphatase-1;
pre-rRNA, precursor ribosomal RNA; rDNA, ribosomal gene; RNA pol,
RNA polymerase; rRNA, ribosomal RNA; SL1, promoter selectivity fac-
tor; TAF
 
I
 
110, TATA-binding protein–associated factor for RNA poly-
merase I; TBP, TATA-binding protein; TTF-1, transcription termination
factor for RNA polymerase I; UBF, upstream binding factor. 
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and Stefanovsky, 1995) remain localized with rDNAs on
chromosomes (Roussel et al., 1993, 1996; Zatsepina et al.,
1993; Weisenberger and Scheer, 1995; Jordan et al., 1996;
Gébrane-Younès et al., 1997). In addition, the transcrip-
tion termination factor TTF-1, which facilitates initiation and
mediates termination of rDNA transcription (Grummt et
al., 1986; Längst et al., 1997, 1998; Sander and Grummt,
1997), is also colocalized with the mitotic rDNA machin-
ery (Sirri et al., 1999). Moreover, complexes engaged in
transcription seem to be present on chromosomes, since
they can be reactivated in vitro by agents blocking new ini-
tiation events (Matsui et al., 1979; Matsui and Sandberg,
1985). Considering these observations, it may be proposed
that the mitotic inactivation of rDNA transcription occurs
at the level of transcription elongation (Weisenberger and
Scheer, 1995). However, mitotic phosphorylation impairs
the interaction of SL1 with UBF, suggesting that phosphor-
ylation might prevent preinitiation complex formation and
shut down rDNA transcription at mitosis (Heix et al.,
1998). Models proposed for repression of RNA pol II–
and III–dependent transcription during mitosis include
phosphorylation that would induce inactivation and dis-
placement of transcription factors (for review see Gottes-
feld and Forbes, 1997). In particular, the majority of RNA
pol II–specific TBP is detached from the chromatin in mi-
tosis (Segil et al., 1996). Conversely, the TBP-containing
factor SL1 is not dispersed during mitosis, whereas it is in-
activated by cdc2–cyclin B kinase–directed phosphoryla-
tion (Heix et al., 1998; Kuhn et al., 1998).
Since the rDNA transcription machinery remains asso-
ciated with rDNAs during mitosis and its repression is
most probably under the control of the cdc2–cyclin B ki-
nase pathway, we anticipated that inactivation of this ki-
nase activity would make it possible to reinduce rDNA
transcription on mitotic chromosomes. Our results show
that cdc2–cyclin B kinase activity is indispensable to main-
tain repression of rDNA transcription during mitosis. The
inhibition of the cdc2–cyclin B kinase induces resumption
of rDNA transcription in colchicine-arrested or metaphase
synchronized mitotic HeLa cells in a manner dependent
on an okadaic acid–sensitive phosphatase. Interestingly,
the newly synthesized 47S pre-rRNA is not processed and
therefore accumulates.
 
Materials and Methods
 
Cell Culture and Synchronization
 
HeLa cells were cultured in MEM (Sigma Chemical Co.)
 
 
 
supplemented
with 10% FCS. For mitosis synchronization, HeLa
 
 
 
cells were exposed to
2 mM
 
 
 
thymidine for 16 h and then resuspended in fresh medium supple-
mented with 24 
 
m
 
M 2
 
9
 
-deoxycytidine and allowed to grow for 9 h.
 
 
 
Thymi-
dine (2 mM) was added again for 16 h, causing cells to accumulate
 
 
 
near the
G1/S boundary. The mitotic cells evaluated to represent 90% of the total
cells were collected at 11 h after release from the double thymidine block.
HeLa cells were also blocked in mitosis (prometaphase) by colchicine
treatment (0.02 
 
m
 
g/ml for 14 h). Mitotic cells
 
 
 
were harvested by mechani-
cal shock.
 
Kinase Inhibitor Treatments
 
A highly selective inhibitor, roscovitine (BIOMOL Research Laborato-
ries) was used to inhibit cdc2–cyclin B kinase. Colchicine-arrested mitotic
HeLa cells were treated or not with okadaic acid (0.5 
 
m
 
M) or actinomycin
D (0.05 
 
m
 
g/ml) for 1 h. Thereafter, 150 
 
m
 
M roscovitine was added for 30
 
min. Mitotic HeLa cells obtained by double thymidine block were treated
with taxol (5 
 
m
 
g/ml) and 150 
 
m
 
M roscovitine for 30 min.
 
Antibodies and Probes
 
The human autoimmune sera with specificity against UBF (A17) and
TTF-1 (P21) have been described (Roussel et al., 1993; Sirri et al., 1999).
The rabbit polyclonal antiphosphohistone H1 antibodies and the MPM-2
detection kit were from Upstate Biotechnology. The goat polyclonal anti–
TBP-associated factor for RNA pol I (TAF
 
I
 
110)
 
 
 
(C-18) antibodies and
rabbit polyclonal anti-TBP (N-12) antibodies were from Santa Cruz Bio-
technology, Inc. The mouse monoclonal anti–
 
b
 
-tubulin antibody was from
Zymed Laboratories, Inc. Texas red–conjugated secondary antibodies
specific for human and rabbit IgGs, FITC-conjugated goat anti–mouse an-
tibodies, peroxidase-conjugated secondary antibodies specific for human
IgAs and human IgGs were obtained from Jackson ImmunoResearch
Laboratories, Inc. Peroxidase-conjugated secondary antibodies specific
for rabbit IgGs and goat IgGs were obtained from Amersham France and
Sigma Chemical Co., respectively.
The 5
 
9
 
-external transcribed spacer (ETS) leader rDNA probe was an
EcoRI-SapI fragment of human rDNA (nucleotide 
 
2
 
512/
 
1
 
420) prepared
from pB
 
ES
 
 (Wilson et al., 1982), and the 5
 
9
 
-ETS core rDNA probe (pB
 
SS
 
;
Wilson et al., 1982) was a SalI-SalI fragment of human rDNA (nucleotide
 
1
 
693/
 
1
 
2921).
 
Immunoblotting
 
For protein analysis, the cells were resuspended in SDS-PAGE sample
buffer (Laemmli, 1970), sonicated, boiled for 5 min, and centrifuged. The
supernatant corresponding to the same number of cells was loaded into
the gel and proteins
 
 
 
were
 
 
 
run on a 12% polyacrylamide (acrylamide/bis-
acrylamide, 30:0.2)-SDS gel and electrotransferred to nitrocellulose mem-
branes (Protran, Schleicher & Schuell). Membranes were blotted with anti-
bodies to UBF, TTF-1, TBP, TAF
 
I
 
110, and phosphohistone H1 as described
previously (Sirri et al., 1999).
 
Assay of RNA Pol Activity In Situ and 
Immunofluorescence Labeling
 
The cells were washed in PBS and transferred onto poly-
 
L
 
-lysine–coated
glass slides. The assay of in situ RNA pol activity was performed as de-
scribed previously (Roussel et al., 1996) in conditions set up to reveal
RNA pol I and RNA pol II transcription (Moore and Ringertz, 1973).
Bromo-uridine 5
 
9
 
-triphosphate (BrUTP) incorporation was detected by
immunofluorescence labeling using a mouse monoclonal anti-BrdU anti-
body (Boehringer Mannheim) revealed by FITC-conjugated goat anti–
mouse antibodies. UBF was simultaneously detected using serum A17
(Roussel et al., 1993) and revealed by Texas red–conjugated goat anti–human
antibodies. Phosphorylated histone H1 was detected with rabbit poly-
clonal antiphosphohistone H1 antibodies followed by Texas red–conju-
gated goat anti–rabbit antibodies. DNA was visualized with 4,6-diami-
dino-2-phenylindole (DAPI).
Fluorescent microscopy was performed using a CCD camera Leitz
DMRB. Images were then assembled using Adobe Photoshop and printed
directly from the computer on a printer (ColorEase PS Printer; Eastman-
Kodak Co.).
 
Metabolic Labeling and Northern Blot Analysis
 
For RNA analysis, colchicine-arrested mitotic HeLa cells were metaboli-
cally labeled or not for 3 h with [
 
32
 
P]orthophosphate at a final concentra-
tion of 250 
 
m
 
Ci/ml (ICN Biomedicals) in phosphate-free MEM. During
metabolic labeling, the cells were treated or not with okadaic acid (0.5 
 
m
 
M)
or actinomycin D (0.05 
 
m
 
g/ml) for 1 h. Roscovitine (150 
 
m
 
M) was then
added for 30 min. Total RNAs were isolated using the kit, RNA NOW
(Biogentex). The 
 
32
 
P-labeled RNAs were separated by electrophoresis on
1% agarose formaldehyde gels. The RNAs were transferred to positively
charged membranes (Boehringer Mannheim). After UV cross-linking, au-
toradiographies were performed with a PhosphorImager (Molecular Dy-
namics, Inc.). The size of the RNAs was determined by comparison to an
RNA ladder (GIBCO BRL). In parallel, the unlabeled RNAs were run in
0.75% agarose formaldehyde gels and transferred to positively charged
membranes. The 5
 
9
 
-ETS core rDNA and 5
 
9
 
-ETS leader rDNA probes were
labeled with [
 
a
 
32
 
P]dCTP by nick translation (GIBCO BRL). The mem-
branes were prehybridized for 5 h at 42
 
8
 
C in buffer containing 50% form- 
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amide, 5
 
3
 
 SSPE, 10
 
3
 
 Denhardt’s solution, 0.1% SDS, and 50 
 
m
 
g/ml salmon
sperm DNA (Maniatis et al., 1982). Hybridization with the radio-labeled
probes was carried out in the same buffer for 24 h at 42
 
8
 
C. After hybridiza-
tion, the membranes were washed twice for 10 min each in 2
 
3
 
 SSC and
0.1% SDS at 65
 
8
 
C, and finally once for 5 min in 0.1
 
3
 
 SSC and 0.1% SDS at
65
 
8
 
C. Autoradiographies were performed with a PhosphorImager.
 
Results
 
Mitotic Repression of Transcription Is Abolished by 
Inhibition of the cdc2–cyclin B Kinase Pathway
 
Global inhibition of transcription occurring during mitosis
in higher eukaryotes appears at the G2/M transition phase
when the cdc2–cyclin B kinase is activated. To determine
whether the cdc2–cyclin B kinase pathway is responsible in
vivo for the mitotic inhibition of transcription, in situ tran-
scription assays were carried out on colchicine-arrested mi-
totic HeLa cells treated or not with roscovitine, a highly se-
lective inhibitor of cyclin-dependent kinases (De Azevedo
et al., 1997; Meijer et al., 1997). Several cyclin-dependent ki-
nases including cdc2–cyclin B and cdk2–cyclin A or E are
very sensitive to roscovitine (IC
 
50 
 
, 
 
7 
 
m
 
M) when tested in
vitro. However, because cdk2–cyclin E and cdk2–cyclin A
are active at the G1/S transition and during S phase, respec-
tively, the cdc2–cyclin B kinase is the only known kinase in-
hibited by roscovitine when mitotically synchronized cells
are treated with this inhibitor. The inhibition of the cdc2–
cyclin B kinase after roscovitine treatment was verified by
analysis of the level of the hyperphosphorylated form of
histone H1, a well-characterized substrate for cdc2–cyclin B
kinase. As expected, no transcription activity was observed
by in situ transcription assays set up to reveal both RNA pol
I and RNA pol II transcription in colchicine-arrested mi-
totic HeLa cells (Fig. 1 b) and the hyperphosphorylated
form of histone H1 was detected (Fig. 1 c). More interest-
ingly, when cells were treated with roscovitine for 30 min
before being processed for in situ transcription assays, tran-
scription activity was detected in 
 
z
 
60% of the cells as deter-
mined by the incorporation of BrUTP appearing in spots in
association with chromosomes (Fig. 1 e). The inhibition of
the cdc2–cyclin B kinase after roscovitine treatment was
demonstrated by the low level of the hyperphosphorylated
form of histone H1 in a large proportion of cells (compare
Fig. 1, c and f). By analyzing simultaneously both the level
of phosphohistone H1 and BrUTP incorporation, we could
relate the inhibition of the cdc2–cyclin B kinase to the re-
sumption of transcription activity. Conversely, cells showing
a high level of the hyperphosphorylated form of histone H1
did not exhibit any transcription activity (Fig. 1, e and f, ar-
rowheads). The resumption of transcription in mitotic cells
after roscovitine treatment was dependent on an okadaic
acid–sensitive phosphatase as shown in Fig. 1 h. Indeed, nei-
ther dephosphorylation of histone H1 (compare Fig. 1, f and
i) nor restoration of transcription activity was observed
when cells were treated with both roscovitine and okadaic
acid before being processed for in situ transcription assays
(compare Fig. 1, e and h).
 
Inhibition of the cdc2–cyclin B Kinase Pathway 
Specifically Restores rDNA Transcription in
Mitotic Cells
 
Inhibition of the cdc2–cyclin B kinase pathway by rosco-
 
vitine treatment in colchicine-arrested mitotic HeLa cells
leads rapidly to the recovery of transcription activity in a
major proportion of the cells as demonstrated by in situ
BrUTP incorporation. The fluorescent patterns observed
in the same cells for BrUTP incorporation and for UBF
showed that both labelings were superimposable (Fig. 2, e
and f). The localization of UBF, and consequently of the
rDNA transcription machinery, and the detection of tran-
scription activity made it possible to observe that after in-
hibition of the cdc2–cyclin B kinase pathway, the tran-
scription activity was restored at nucleolar organizer
regions (NORs), i.e., in chromosomal sites where rDNAs
associated with the rDNA transcription machinery clus-
tered during mitosis. This observation suggests that the
transcription activity that had resumed in colchicine-
arrested mitotic cells most probably corresponded to
rDNA transcription. This was confirmed by results ob-
tained when mitotic cells were treated with a low concen-
tration (0.05 
 
m
 
g/ml) of actinomycin D known to inhibit
rDNA transcription in vivo. As shown in Fig. 2 h, the tran-
scription activity observed in mitotic cells after roscovitine
treatment was hypersensitive to actinomycin D. In conclu-
sion, cdc2–cyclin B kinase activity is indispensable to main-
tain mitotic silencing of rDNA transcription, and its inhibi-
tion restores rDNA transcription in mitotic cells, whereas
no RNA pol II–dependent transcription is detected.
 
Restoration of rDNA Transcription in Mitotic Cells 
Leads to Accumulation of the Unprocessed
47S Pre-rRNA
 
To definitively establish that rDNA transcription is re-
stored in roscovitine-treated mitotic cells and to determine
what rRNA transcript is synthesized, colchicine-arrested
mitotic HeLa cells were metabolically labeled with [
 
32
 
P]or-
thophosphate. Cellular RNAs were extracted, separated
on agarose formaldehyde gels, transferred to nylon mem-
branes, and the 
 
32
 
P-labeled RNA was recorded using a
PhosphorImager (Fig. 3 A). To identify the newly synthe-
sized RNA, the same experiment was reproduced without
 
32
 
P metabolic labeling, and cellular RNA was hybridized
with a 
 
32
 
P-labeled 5
 
9
 
-ETS core rDNA probe recognizing
both the partially processed (45S and 46S) and the unpro-
cessed (47S) pre-rRNAs (Fig. 3 B, lanes a
 
9
 
–d
 
9
 
), and with a
 
32
 
P-labeled 5
 
9
 
-ETS leader rDNA probe recognizing specif-
ically the unprocessed 47S pre-rRNA (Fig. 3 B, lanes e
 
9
 
–h
 
9
 
).
In colchicine-arrested mitotic HeLa cells (Fig. 3 A, lanes a
and a
 
9
 
), several RNA species appeared weakly 
 
32
 
P-labeled
after 
 
32
 
P metabolic labeling (Fig. 3 A, lane a
 
9
 
). This was
most probably due to the presence of 2–5% of contaminat-
ing interphase cells as assessed by microscope observa-
tions (data not shown). When colchicine-arrested mitotic
HeLa cells were treated with roscovitine (Fig. 3 A, lanes b
and b
 
9
 
), a large RNA was synthesized (Fig. 3 A, lane b
 
9
 
).
This RNA, whose synthesis is inhibited by 0.05 
 
m
 
g/ml acti-
nomycin D (Fig. 3 A, compare lanes b
 
9
 
 and c
 
9
 
), was identi-
fied by Northern blot analyses as pre-rRNA (Fig. 3 B,
lanes b
 
9
 
 and f
 
9
 
). As observed by in situ transcription assays
(Fig. 1), resumption of rDNA transcription triggered by
roscovitine treatment is abolished if the roscovitine effects
are counteracted by okadaic acid treatment (Fig. 3 A, lane
d
 
9
 
). It is noteworthy that the levels of 
 
32
 
P-labeled 28S and 
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18S rRNA did not vary (Fig. 3 A, compare lanes a
 
9
 
 and
b
 
9
 
). Therefore, the newly synthesized pre-rRNA did not
seem to be processed into mature rRNAs. The absence of
any processing of the newly synthesized pre-rRNA is sup-
ported by Northern blot analyses using the 5
 
9
 
-ETS core
rDNA probe of pre-rRNA present in mitotic cells (Fig. 3
B, lanes a and a
 
9
 
) for which rDNA transcription was re-
stored by roscovitine treatment (Fig. 3 B, lanes b and b
 
9
 
),
and in mitotic cells for which rDNA transcription was si-
multaneously restored by roscovitine and inhibited by ac-
tinomycin D treatment (Fig. 3 B, lanes c and c
 
9
 
). Indeed,
the partially processed pre-rRNA known to be present in
mitotic cells (Dundr and Olson, 1998; Fig. 3 B, lane a
 
9
 
) was
actively processed and/or degraded after roscovitine treat-
ment, and consequently, largely decreased as observed
when rDNA transcription was simultaneously restored by
roscovitine and inhibited by actinomycin D treatment
(Fig. 3 B, compare lanes a
 
9
 
 and c
 
9
 
). As a consequence, we
can conclude that the pre-rRNA easily detectable in mi-
totic cells treated with roscovitine (Fig. 3 B, lane b
 
9
 
) corre-
sponds to newly synthesized pre-rRNA, which is not pro-
cessed and therefore accumulates. The electrophoretic
behavior of this pre-rRNA present in mitotic cells treated
with roscovitine (Fig. 3 B, lane b
 
9
 
) argues in favor of the
absence of any processing event of the newly synthesized
pre-rRNA, even of the primary processing events. Indeed
this pre-rRNA migrates slightly slower than the partially
processed pre-rRNA present in mitotic cells (Fig. 3 B,
compare lanes a
 
9
 
 and b
 
9
 
). This is confirmed using the 5
 
9
 
-
ETS leader rDNA probe, which recognizes specifically the
Figure 1. Mitotic repression
of transcription is abolished by
roscovitine treatment. HeLa
cells blocked in mitosis by
colchicine treatment (0.02 mg/
ml for 14 h) were treated
(d–f) or not (a–c) with 150
mM roscovitine, a specific in-
hibitor of cdc2–cyclin B ki-
nase, for 30 min. Mitotic cells
were also treated with 0.5 mM
okadaic acid for 1 h before
addition of 150 mM rosco-
vitine for 30 min (g–i). Tran-
scription activity was revealed
by the detection of in situ in-
corporation of BrUTP in con-
ditions favoring both RNA
pol I and RNA pol II activity
(b, e, and h). Simultaneously,
the inhibition of cdc2–cyclin
B kinase was verified by the
detection of the hyperphos-
phorylated form of histone
H1 (c, f, and i). The chromo-
somes were stained with
DAPI (a, d, and g). In control
cells (a–c) no transcription
activity was detected (b) and
histone H1 was hyperphos-
phorylated (c). In roscovitine-
treated cells (d–f) transcrip-
tion activity was detected (e)
in mitotic cells negative for
hyperphosphorylated histone
H1 (f). Arrowheads indicate
cells positive for phosphoryla-
tion of histone H1 (f) and
negative for transcription ac-
tivity (e). In mitotic cells, ad-
ditionally pretreated with
okadaic acid (g–i), neither de-
phosphorylation of histone
H1 (i) nor transcription activ-
ity (h) was detected. The inhi-
bition of cdc2–cyclin B kinase
abolished mitotic repression
of transcription dependent on
an okadaic acid–sensitive
phosphatase. Bar, 10 mm. 
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unprocessed 47S pre-rRNA (Fig. 3 B, lane f
 
9
 
), and there-
fore we can conclude that restoration of rDNA transcrip-
tion in mitotic cells leads to accumulation of the unpro-
cessed 47S pre-rRNA. On the other hand it is interesting
to note that processing and/or degradation of the partially
processed pre-rRNA present in mitotic cells (Dundr and
Olson, 1998; Fig. 3 B, lane a
 
9
 
) that occurs after roscovitine
treatment (Fig. 3 B, lane c
 
9
 
) is no longer observed in the
presence of okadaic acid (Fig. 3 B, lane d
 
9
 
).
 
Mitotically Phosphorylated Forms of Components of the 
rDNA Transcription Machinery Are Dephosphorylated 
by Roscovitine Treatment
 
Several components of the rDNA transcription machin-
ery, TAF
 
I
 
110, and TBP (Heix et al., 1998), UBF (Klein
and Grummt, 1999), and more recently TTF-1 (Sirri et al.,
1999) were reported to be phosphorylated during mitosis.
Except for UBF, mitotic phosphorylation was shown to
modify the electrophoretic mobility of these components
(Heix et al., 1998; Sirri et al., 1999), and is therefore easily
observed. As shown in Fig. 4, TTF-1, TAF
 
I
 
110, and TBP
migrated slower in colchicine-arrested mitotic HeLa cells
(Fig. 4, lane 2) than in interphase cells (Fig. 4, lane 1).
When mitotic cells were treated for 30 min with rosco-
vitine, phosphorylation of these components was largely
reversed, as demonstrated by their electrophoretic migra-
tion (compare Fig. 4, lanes 1 and 3). The dephosphoryla-
tion, occurring when cdc2–cyclin B kinase is inhibited,
implicated the activity of an okadaic acid–sensitive phos-
Figure 2. Roscovitine treat-
ment relieves mitotic silenc-
ing of rDNA transcription.
HeLa cells blocked in mitosis
by colchicine treatment (0.02
mg/ml for 14 h) were treated
(d–f) or not (a–c) with 150
mM roscovitine for 30 min.
Mitotic cells were also treated
with a low concentration of
actinomycin D (0.05 mg/ml
for 1 h) before roscovitine
treatment (g–i). Transcription
activity was detected by in
situ BrUTP incorporation in
conditions favoring both
RNA pol I and RNA pol II
activity (b, e, and h). Local-
ization of the rDNA tran-
scription machinery was re-
vealed by UBF localization
(c, f, and i). In roscovitine-
treated cells the sites of
BrUTP incorporation (e)
were superimposable to the
sites of localization of the
rDNA transcription machin-
ery revealed by UBF labeling
(f). The actinomycin D treat-
ment abolished this transcrip-
tion activity. No incorpora-
tion of BrUTP was detected
in actinomycin D–treated
cells (h) as for control cells
(b). Bar, 10 mm. 
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phatase as observed in Fig. 4, lane 4. Indeed, if mitotic
cells were treated previously with okadaic acid, subse-
quent roscovitine treatment produced no effect on the
phosphorylation state of these components. On the other
hand, dephosphorylation is obviously not a consequence
of the restoration of rDNA transcription activity. Inhibi-
tion of rDNA transcription by actinomycin D did not af-
fect dephosphorylation from occurring when mitotic cells
were treated with roscovitine (Fig. 4, lane 5). In this series
of experiments, cdc2–cyclin B kinase activity was detected
by analyzing the level of the hyperphosphorylated form of
histone H1. The hyperphosphorylated form of histone H1,
only present in mitotic cells (compare Fig. 4, lanes 1 and
2), disappeared when mitotic cells were treated with rosco-
vitine (Fig. 4, lane 3) or with both roscovitine and actino-
mycin D (Fig. 4, lane 5). The absence of histone H1 de-
phosphorylation when mitotic cells were treated with both
roscovitine and okadaic acid (Fig. 4, lane 4) is explained by
the fact that okadaic acid inhibits protein phosphatase-1
(PP-1), which is required for dephosphorylation of histone
H1 (Paulson et al., 1996). Considering these results and
those reported above, it seems clearly established that the
mitotic repression of rDNA transcription is dependent on
phosphorylation events, and most probably on phosphory-
lation of components of the rDNA transcription machin-
ery. Inhibition of the cdc2–cyclin B kinase is sufficient to
restore rDNA transcription activity only if no okadaic
acid–sensitive phosphatase is inhibited. This observation
suggests that cdc2–cyclin B kinase might repress rDNA
transcription during mitosis by inhibiting an okadaic acid–
sensitive phosphatase. Nevertheless, we cannot rule out
the possibility that inhibition of an okadaic acid–sensitive
phosphatase counteracts the roscovitine effect by increas-
ing cdc2–cyclin B kinase activity.
 
The Resumption of rDNA Transcription Activity Is Not 
a Consequence of Exit from Mitosis
 
During the cell cycle, mitotic repression of rDNA tran-
scription is released at telophase when cells exit from mi-
tosis. Therefore, it may be asked whether the inhibition of
cdc2–cyclin B kinase in colchicine-arrested mitotic cells in-
duces exit from mitosis, and consequently derepression of
rDNA transcription, or whether cdc2–cyclin B kinase di-
Figure 3. Identification of RNAs synthesized after roscovitine treatment in mitotic cells. (A) Colchicine-arrested mitotic HeLa cells
were metabolically labeled with [32P]orthophosphate (250 mCi/ml). During labeling, cells were treated or not with okadaic acid (OA) or
actinomycin D (AMD) for 1 h, after which roscovitine (Rosc) was added for 30 min. The RNAs corresponding to 8 3 105 cells were an-
alyzed. (A, lanes a–d) RNAs detected in 1% agarose gel by ethidium bromide staining. (A, lanes a9–d9) RNAs detected after autora-
diography. In roscovitine-treated cells (A, lane b9) an intense, slowly migrating RNA is synthesized (A, arrow) when compared with the
control cells (A, lane a9). Synthesis of RNA was abolished by actinomycin D (A, lane c9) and okadaic acid treatment (A, lane d9). (B)
The same experiment was reproduced without metabolic labeling and the RNAs were analyzed by Northern blot using 32P-labeled
59-ETS core or 32P-labeled 59-ETS leader rDNA probes. (B, lanes a–h) RNAs detected in 0.75% agarose gel by ethidium bromide stain-
ing. (B, lanes a9–d9) Blot hybridized with a 32P-labeled 59-ETS core rDNA probe to identify the 47–45S pre-rRNAs. In extracts prepared
from roscovitine-treated mitotic cells (B, lane b9) the pre-rRNA detected by the 59-ETS core rDNA probe migrated slightly slower than
in those prepared from control cells (B, lane a9) and from mitotic cells treated with both actinomycin D and roscovitine (B, lane c9) or
with both okadaic acid and roscovitine (B, lane d9). When mitotic cells were treated with actinomycin D and roscovitine, the level of
pre-rRNA was largely decreased (B, lane c9). (B, lanes e9–h9) Blot hybridized with a 32P-labeled 59-ETS leader rDNA probe to specifi-
cally identify the unprocessed 47S pre-rRNA. The unprocessed 47S pre-rRNA accumulated in extracts prepared from roscovitine-
treated mitotic cells (B, lane f9) contrary to those prepared from control cells (B, lane e9) and from mitotic cells treated with actinomy-
cin D and roscovitine (B, lane g9) or with okadaic acid and roscovitine (B, lane h9).Sirri et al. Resumption of rDNA Transcription in Mitotic Cells 265
rectly regulates rDNA transcription. To address this ques-
tion, roscovitine treatments were reproduced using syn-
chronized mitotic HeLa cells. The population of mitotic
cells used was collected 11 h after release from a double
thymidine block and treated or not with roscovitine for 30
min. As illustrated in Fig. 5, control cells (Fig. 5, a and b)
exhibited a large percentage of prometaphase and meta-
phase cells (z50%), whereas among roscovitine-treated
cells (Fig. 5, d and e), very few if any were found at these
middle mitotic stages. Obviously the roscovitine treatment
caused an accelerated and most probably abnormal prog-
ress through mitosis, and cells appeared in later mitotic
stages. As shown in Fig. 5 f, by in situ transcription, most
roscovitine-treated cells exhibited rDNA transcription,
but it was impossible to say if resumption of rDNA tran-
scription was directly due to inhibition of cdc2–cyclin B ki-
nase or to accelerated progress through mitosis.
To overcome this problem, a population of mitotic cells
enriched in middle mitotic stages was treated (Fig. 6, e–h)
or not (Fig. 6, a–d) with roscovitine for 30 min, and the
same population of mitotic cells was treated with both ros-
covitine and the microtubule poison taxol for the same
length of time (Fig. 6, i–l). Cells were analyzed by DNA
and b-tubulin staining to follow progress through mitosis.
As reported above, roscovitine treatment accelerated
progress through mitosis as shown by the disappearance of
prometaphase and metaphase cells (Fig. 6; compare Fig. 6,
a–d and Fig. 6, e–h). When cells were treated with both
roscovitine and taxol, the microtubule stabilization effect
obtained by taxol treatment reversed the effect of rosco-
vitine on the kinetics of mitosis. As observed when Fig. 6,
a–d are compared with Fig. 6, i–l, prometaphase and
metaphase cells are maintained. We also analyzed dere-
pression of rDNA transcription by in situ transcription as-
says (Fig. 7, g and k), and either UBF localization (Fig. 7 h)
or cdc2–cyclin B kinase activity by hyperphosphorylated
histone H1 detection (Fig. 7 l). The results obtained are
similar to those obtained on colchicine-arrested mitotic
cells, i.e., transcription is restored in prometaphase and
metaphase cells at NORs, where the rDNA transcription
machinery is localized in association with rDNAs during
mitosis (compare Fig. 7, g and h) only in cells for which
cdc2–cyclin B kinase activity is actually inhibited as dem-
onstrated by the disappearance of hyperphosphorylated
histone H1 (compare Fig. 7, k and l). Therefore, the re-
sumption of rDNA transcription in mitotic cells is not de-
pendent on completion of mitosis nor is it a consequence
of exit from mitosis. Inhibition of cdc2–cyclin B kinase re-
lieves mitotic silencing of rDNA transcription in meta-
phase HeLa cells (Fig. 8) independently of separation of
sister chromatids and chromosome decondensation. The
same conclusion is derived from results obtained when
MPM-2 antibody, which recognizes mitosis-specific epi-
topes (Davis et al., 1983), is used on colchicine-arrested
mitotic HeLa cells treated with roscovitine. No loss of re-
activity with the MPM-2 antibody, characterizing exit from
mitosis (Andreassen and Margolis, 1994), is observed in
colchicine-arrested mitotic HeLa cells exhibiting rDNA
transcription activity (data not shown).
Discussion
Mitotic Silencing of rDNA Transcription
It is now well-established that cdc2–cyclin B kinase–
directed phosphorylation plays a key role in mitotic re-
pression of RNA pol I– (Heix et al., 1998; Kuhn et al.,
1998), RNA pol II– (Leresche et al., 1996; Long et al.,
1998), and RNA pol III–dependent (Hartl et al., 1993;
Leresche et al., 1996; Gottesfeld and Forbes, 1997) tran-
scription. Our results show that the cdc2–cyclin B kinase is
not only necessary to establish rDNA transcription repres-
sion as proposed for the mitotic repression of RNA pol III
transcription (Hartl et al., 1993), but also to maintain re-
pression from prophase to telophase. Indeed, reactivation
Figure 4. Mitotically phosphorylated forms of components of the
rDNA transcription machinery are dephosphorylated by rosco-
vitine treatment. Immunoblots of unsynchronized HeLa cells
(lane 1) and colchicine-arrested mitotic HeLa cells (lanes 2–5)
not treated with roscovitine (lane 2) or treated with roscovitine
(1Ros; lane 3), with both okadaic acid and roscovitine (1OA
1Ros; lane 4), or with both actinomycin D and roscovitine
(1AMD 1Ros; lane 5) probed with antibodies directed against
different components of the rDNA transcription machinery
(TTF-1, TAFI110, UBF, and TBP). Antiphosphohistone H1 (in-
dicated by H1-circled P) antibodies were used to verify the in-
hibition of cdc2–cyclin B kinase by roscovitine treatment. Un-
synchronized HeLa cells (lane 1) were used to identify the
nonphosphorylated form of the proteins studied. Except for
UBF, the other factors were phosphorylated in untreated mitotic
cells (compare lanes 1 and 2). In mitotic extracts the bands corre-
sponding to TTF-1 and TAFI110 migrated slightly slower (lane 2)
than in interphase extracts (lane 1). For TBP, different phos-
phorylated forms were resolved in mitotic extracts (lane 2).
These mitotic phosphorylations were partially reversed for TTF-1
and completely for TAFI110, TBP, and histone H1 by roscovitine
treatment (compare lanes 1–3). Okadaic acid pretreatment coun-
teracted the effect of roscovitine on mitotic phosphorylation of
these proteins: only hyperphosphorylated forms were visible
(lanes 3 and 4). Pretreatment with actinomycin D did not affect
the dephosphorylation induced by roscovitine treatment (lane 5).The Journal of Cell Biology, Volume 148, 2000 266
of rDNA transcription after in vivo inhibition of the cdc2–
cyclin B kinase pathway in colchicine-arrested and syn-
chronized mitotic cells shows that cdc2–cyclin B kinase ac-
tivity directly controls rDNA transcription during mitosis.
We also show that the cdc2–cyclin B kinase maintains mi-
totic rDNA silencing, most probably by inhibiting an as-
yet unidentified serine/threonine phosphatase. Indeed,
inhibition of the cdc2–cyclin B kinase leads to dephos-
phorylation of the components of the rDNA transcription
machinery specifically phosphorylated during mitosis, i.e.,
TBP, TAFI110, and TTF-1, and consequently to derepres-
sion of mitotic rDNA silencing only in the absence of oka-
daic acid. PP-1, which plays a key role for anaphase pro-
gression and exit from mitosis (Fernandez et al., 1992) and
which is required for dephosphorylation of histone H1
(Paulson et al., 1996), seems to be a good candidate for de-
phosphorylation of components of the rDNA transcrip-
tion machinery. This hypothesis is also supported by the
fact that the PP-1 d isoform remains associated with
chromosomes throughout mitosis (Andreassen et al.,
1998). Moreover, in this work, dephosphorylation of TBP,
TAFI110, and TTF-1 occurs after cdc2–cyclin B kinase in-
hibition in a manner dependent on an okadaic acid–sensi-
tive phosphatase as does dephosphorylation of histone H1.
Derepression of rDNA Transcription Is Not the 
Consequence of Exit from Mitosis and Does Not 
Require Completion of Mitosis
Restoration of rDNA transcription after cdc2–cyclin B ki-
nase inhibition might be interpreted as a consequence of
exit from mitosis. Indeed, it is known that inhibition of mi-
totic kinases by the protein kinase inhibitor 2-aminopurine
induces checkpoint override and mitotic exit in cells ar-
rested in mitosis by inhibitors of microtubule function
(Andreassen and Margolis, 1994). Moreover, as shown in
this study, inhibition of cdc2–cyclin B kinase by rosco-
vitine treatment induces rapid exit from mitosis, most
probably by shunting the spindle-assembly checkpoint.
Nevertheless, we have been able to verify that the reactiv-
ity with MPM-2 antibodies, which recognize mitosis-spe-
cific epitopes (Davis et al., 1983), is maintained in colchi-
cine-arrested mitotic cells treated with roscovitine for 30
min. Moreover, rDNA transcription may be restored in
synchronized metaphase cells treated both by roscovitine
and taxol. Consequently, rDNA transcription is restored
in mitotic cells by inhibition of cdc2–cyclin B kinase activ-
ity. The resumption of rDNA transcription is only depen-
dent on cdc2–cyclin B kinase activity and does not need
progression of cells through late mitotic stages.
Figure 5. Roscovitine treat-
ment causes accelerated and
abnormal progress through
mitosis. Mitotic HeLa cells
were collected 11 h after re-
lease from double thymidine
block and treated (d–f) or not
(a–c) with 150 mM roscovitine
for 30 min. The cells were ana-
lyzed by phase-contrast and
DAPI staining. In the control
cells a large percentage
(z50%) of prometaphase and
metaphase stages (a and b, ar-
rowheads) was detected, con-
trary to roscovitine-treated
cells in which later mitotic
stages were visible (d and e).
rDNA transcription activity
was detected after roscovitine
treatment (f). Bar, 10 mm.Sirri et al. Resumption of rDNA Transcription in Mitotic Cells 267
Mitotic Repression Is Released Successively for the 
Different RNA Pols
During the cell cycle, derepression takes place successively
for the different RNA pols. Whereas RNA pol I transcrip-
tion is reactivated in telophase (Roussel et al., 1996), reac-
tivation of RNA pol III transcription takes place later dur-
ing the G1 phase (White et al., 1995). Moreover, as shown
here, inhibition of cdc2–cyclin B kinase restores rDNA
transcription rapidly and uniquely. The rapid switch-on of
rDNA transcription in telophase or after roscovitine treat-
ment, i.e., when cdc2–cyclin B kinase is inactivated, is most
probably made possible by the fact that, as opposed to
other RNA pol–dependent transcription machineries, the
rDNA transcription machinery is not released from rDNAs
during mitosis. Concerning the molecular basis of mitotic
repression of rDNA transcription, two somewhat con-
tradictory mechanisms have been proposed. The first
mechanism suggests that rDNA transcription is regulated
at the level of transcription elongation (Weisenberger and
Scheer, 1995). This is supported by biochemical experi-
ments (Matsui and Sandberg, 1985) showing that rDNA
transcription may be reactivated in vitro in the presence of
heparin, i.e., an agent that blocks new initiation events,
and by immunocytochemical studies (Zatsepina et al.,
1993; Weisenberger and Scheer, 1995; Jordan et al., 1996;
Roussel et al., 1996; Gébrane-Younès et al., 1997; Sirri et
al., 1999) showing that the rDNA transcription machinery
is never disengaged from rDNAs. The second mechanism
proposed is that mitotic repression of rDNA transcription
takes place at the level of transcription initiation. This is
based on recent results obtained using a reconstituted cell-
free transcription system (Heix et al., 1998) showing that
the mitotic phosphorylation of SL1 impairs the capability
of SL1 to interact with UBF, and therefore prevents prein-
itiation complex formation. Our data do not make it possi-
ble to discriminate between these two mechanisms, but
they establish that whatever the step of the rDNA tran-
scription process affected, the mechanism that represses
Figure 6. Taxol treatment re-
verses the effect of rosco-
vitine on the kinetics of mito-
sis. HeLa cells synchronized
in middle mitotic stages by a
double thymidine block were
not treated (a–d) or treated
with roscovitine (e–h), or with
both roscovitine and taxol
(i–l) for 30 min. The cells
were analyzed by phase-con-
trast (a, e, and i), DAPI stain-
ing (b, f, and j), and b-tubulin
labeling (c, g, and k). (d, h,
and l) Superimposition of
DAPI staining and b-tubu-
lin  labeling. In roscovitine-
treated cells (h), a higher per-
centage of late mitotic stages
than in control cells (d) was
observed. Conversely, addi-
tion of taxol blocked the cells
at middle mitotic stages (l) by
reversing the effect of rosco-
vitine on the kinetics of mito-
sis. Arrowheads (d and l) in-
dicate prometaphase and
metaphase cells. Bar, 10 mm.The Journal of Cell Biology, Volume 148, 2000 268
rDNA transcription during mitosis is reversed in vivo after
inactivation of the cdc2–cyclin B kinase.
Newly Synthesized 47S Pre-rRNA Is Not Processed 
after cdc2–cyclin B Inhibition
In eukaryotes, the rRNAs are cotranscribed as a single
large pre-rRNA that is rapidly processed into the mature
rRNAs (Allmang and Tollervey, 1998). In humans, the 47S
pre-rRNA is processed into the mature 18S, 5.8S, and 28S
rRNAs. Interestingly, the resumption of rDNA transcrip-
tion in mitotic cells does not give rise to processing of the
newly synthesized 47S pre-rRNA. As reported here, when
rDNA transcription is restored, the newly synthesized 47S
pre-rRNA accumulates without increase of the 18S and 28S
rRNA species. These results seem to indicate that when
rDNA transcription is restored, it is uncoupled from 47S
pre-rRNA processing. It is noteworthy that the partially
processed pre-rRNA preserved during mitosis in associa-
tion with pre-rRNA processing components (Dundr and
Olson, 1998) appears to be actively processed after inhibi-
tion of cdc2–cyclin B kinase in colchicine-arrested mitotic
HeLa cells. Our results suggest that the machinery involved
in processing of the partially processed pre-rRNA is also
derepressed by inhibition of cdc2–cyclin B kinase in a man-
ner dependent on an okadaic acid–sensitive phosphatase.
With respect to the newly synthesized 47S pre-rRNA, its
processing could be inhibited at the level of the primary pro-
cessing events that had already taken place for the partially
processed pre-rRNA (Dundr and Olson, 1998), or could be
prevented by the absence of components implicated in pre-
rRNA processing. Indeed, as opposed to the rDNA tran-
scription machinery that remains associated with rDNAs at
the level of NORs during mitosis, the pre-rRNA processing
components appear to be excluded from NORs (Hernandez-
Verdun and Gautier, 1994; Weisenberger and Scheer, 1995).
Pre-rRNA processing components such as fibrillarin, nucleo-
lin, protein B23, and U3 small RNAs leave the NORs and re-
localize around the chromosomes early in prophase (Gautier
et al., 1992, 1994). Normally, at the end of mitosis, in telo-
Figure 7. Roscovitine treat-
ment restores rDNA tran-
scription in metaphase cells.
Mitotic HeLa cells synchro-
nized by a double thymidine
block were treated with taxol
(a–d) or taxol and roscovitine
(e–l) for 30 min. The cells
were processed to detect the
transcription activity (c, g,
and k), and to label UBF (d
and h) and the hyperphos-
phorylated form of histone
H1 (l). The mitotic stages
were visualized by phase-con-
trast (a, e, and i) and DAPI
staining (b, f, and j). The ros-
covitine treatment was suffi-
cient to restore transcription
activity in metaphase (g and
k). This transcription activity
was detected at the NORs,
where UBF is localized (com-
pare g and h), only in cells in
which cdc2–cyclin B kinase
was actually inhibited as evi-
denced by the absence of the
hyperphosphorylated form of
histone H1 (compare k and l).
Asterisk (e) indicates the cell
for which enlargement is
shown in Fig. 8. Bar, 10 mm.Sirri et al. Resumption of rDNA Transcription in Mitotic Cells 269
phase, these components are recruited in prenucleolar bodies
(Fomproix et al., 1998) that relocalize to transcription sites,
i.e., the reforming nucleoli, with different kinetics (Westen-
dorf et al., 1998; Fomproix and Hernandez-Verdun, 1999;
Savino et al., 1999). It is presently unknown how the coordi-
nation between rDNA transcription activation and targeting
of the rRNA processing machinery to sites of transcription is
controlled at the end of mitosis. In this study, the accumula-
tion of the newly synthesized 47S pre-rRNA suggests that the
activity of one or several factors involved in pre-rRNA pro-
cessing are not under the control of the cdc2–cyclin B kinase
or that the relocalization of the pre-rRNA processing ma-
chinery is not regulated by this kinase. Further investigations
are necessary to establish the fate of the pre-rRNA process-
ing components in relation to resumption of pre-rRNA pro-
cessing when rDNA transcription is restored in mitotic cells.
The authors thank J.E. Sylvester for the gift of rDNA-containing plas-
mids, and A.L. Haenni for critical reading of the manuscript. 
This work was supported in part by grants from the Centre National de
la Recherche Scientifique and the Association pour la Recherche sur le
Cancer (Contracts 9143 and 5304). V. Sirri is the recipient of a grant from
the Centre National de la Recherche Scientifique.
Submitted: 4 October 1999
Revised: 7 December 1999
Accepted: 14 December 1999
References
Allmang, C., and D. Tollervey. 1998. The role of the 39 external transcribed
spacer in yeast pre-rRNA processing. J. Mol. Biol. 278:67–78.
Andreassen, P.R., and R.L. Margolis. 1994. Microtubule dependency of p34cdc2
inactivation and mitotic exit in mammalian cells. J. Cell Biol. 127:789–802.
Andreassen, P.R., F.B. Lacroix, E. Villa-Moruzzi, and R.L. Margolis. 1998. Dif-
ferential subcellular localization of protein phosphatase-1 a, g1, and d iso-
forms during both interphase and mitosis in mammalian cells. J. Cell Biol.
141:1207–1215.
Davis, F.M., T.Y. Tsao, S.K. Fowler, and P.N. Rao. 1983. Monoclonal antibod-
ies to mitotic cells. Proc. Natl. Acad. Sci. USA. 80:2926–2930.
De Azevedo, W.F., S. Leclerc, L. Meijer, L. Havlicek, M. Strnad, and S.-H.
Kim. 1997. Inhibition of cyclin-dependent kinases by purines analogues:
crystal structure of human cdk2 complexed with roscovitine. Eur. J. Bio-
chem. 243:518–526.
Dundr, M., and M.O.J. Olson. 1998. Partially processed pre-rRNA is preserved
in association with processing components in nucleolus-derived foci during
mitosis. Mol. Biol. Cell. 9:2407–2422.
Fan, H., and S. Penman. 1971. Regulation of synthesis and processing of nucle-
olar components in metaphase-arrested cells. J. Mol. Biol. 59:27–42.
Fernandez, A., D.L. Brautigan, and N.J.C. Lamb. 1992. Protein phosphatase
type 1 in mammalian cell mitosis: chromosomal localization and involve-
ment in mitotic exit. J. Cell Biol. 116:1421–1430.
Fomproix, N., and D. Hernandez-Verdun. 1999. Effects of anti-PM-Scl 100
(Rrp6p exonuclease) antibodies on prenucleolar body dynamics at the end
of mitosis. Exp. Cell Res. 251:452–464.
Fomproix, N., J. Gébrane-Younès, and D. Hernandez-Verdun. 1998. Effects of
anti-fibrillarin antibodies on building of functional nucleoli at the end of mi-
tosis. J. Cell Sci. 111:359–372.
Gautier, T., M. Robert-Nicoud, M.-N. Guilly, and D. Hernandez-Verdun. 1992.
Relocation of nucleolar proteins around chromosomes at mitosis: a study by
confocal laser scanning microscopy. J. Cell Sci. 102:729–737.
Gautier, T., N. Fomproix, C. Masson, M.C. Azum-Gélade, N. Gas, and D. Her-
nandez-Verdun. 1994. Fate of specific nucleolar perichromosomal proteins
during mitosis: cellular distribution and association with U3 snoRNA. Biol.
Cell. 82:81–93.
Gébrane-Younès, J., N. Fomproix, and D. Hernandez-Verdun. 1997. When
rDNA transcription is arrested during mitosis, UBF is still associated with
non-condensed rDNA. J. Cell Sci. 110:2429–2440.
Gottesfeld, J.M., and D.J. Forbes. 1997. Mitotic repression of the transcrip-
tional machinery. TIBS (Trends Biochem. Sci.). 22:197–202.
Grummt, I., H. Rosenbauer, I. Niedermeyer, U. Maier, and A. Ohrlein. 1986. A
repeated 18 bp sequence motif in the mouse rDNA spacer mediates binding
of a nuclear factor and transcription termination. Cell. 45:837–846.
Hartl, P., J. Gottesfeld, and D.J. Forbes. 1993. Mitotic repression of transcrip-
tion in vitro. J. Cell Biol. 120:613–624.
Heix, J., A. Vente, R. Voit, A. Budde, T.M. Michaelidis, and I. Grummt. 1998.
Mitotic silencing of human rRNA synthesis: inactivation of the promoter se-
lectivity factor SL1 by cdc2/cyclin B-mediated phosphorylation. EMBO
(Eur. Mol. Biol. Organ.) J. 17:7373–7381.
Hernandez-Verdun, D., and T. Gautier. 1994. The chromosome periphery dur-
ing mitosis. Bioessays. 16:179–185.
Jordan, P., M. Mannervik, L. Tora, and M. Carmofonseca. 1996. In vivo evi-
dence that TATA-binding protein SL1 colocalizes with UBF and RNA poly-
merase I when rRNA synthesis is either active or inactive. J. Cell Biol. 133:
225–234.
Klein, J., and I. Grummt. 1999. Cell cycle-dependent regulation of RNA poly-
merase I transcription: the nucleolar transcription factor UBF is inactive in
mitosis and early G1. Proc. Natl. Acad. Sci. USA. 96:6096–6101.
Kuhn, A., A. Vente, M. Dorée, and I. Grummt. 1998. Mitotic phosphorylation
of the TBP-containing factor SL1 represses ribosomal gene transcription. J.
Mol. Biol. 284:1–5.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature. 227:680–685.
Längst, G., T.A. Blank, P.B. Becker, and I. Grummt. 1997. RNA polymerase I
transcription on nucleosomal templates: the transcription termination factor
TTF-1 induces chromatin remodeling and relieves transcriptional repres-
sion.  EMBO (Eur. Mol. Biol. Organ.) J. 16:760–768.
Längst, G., P.B. Becker, and I. Grummt. 1998. TTF-1 determines the chromatin
architecture of the active rDNA promoter. EMBO (Eur. Mol. Biol. Organ.)
J. 17:3135–3143.
Leresche, A., V.J. Wolf, and J.M. Gottesfeld. 1996. Repression of RNA poly-
merase II and III transcription during M phase of the cell cycle. Exp. Cell
Res. 229:282–288.
Long, J.J., A. Leresche, R.W. Kriwacki, and J.M. Gottesfeld. 1998. Repression
of TFIIH transcriptional activity and TFIIH-associated cdk7 kinase activity
at mitosis. Mol. Cell. Biol. 18:1467–1476.
Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Labo-
ratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
9.47–9.55.
Matsui, S., and A.A. Sandberg. 1985. Intranuclear compartmentalization of
DNA-dependent RNA polymerases: association of RNA polymerase I with
nucleolar organizing chromosomes. Chromosoma. 92:1–6.
Matsui, S.-I., H. Weinfeld, and A.A. Sandberg. 1979. Quantitative conservation
of chromatin-bound RNA polymerases I and II in mitosis. J. Cell Biol. 80:
451–464.
Meijer, L., A. Borgne, O. Mulner, J.P.J. Chong, J.J. Blow, N. Inagaki, M. Ina-
gaki, J.-G. Delcros, and J.-P. Moulinoux. 1997. Biochemical and cellular ef-
fects of roscovitine, a potent and selective inhibitor of the cyclin-dependent
Figure 8. After roscovitine treatment, the sites of rDNA tran-
scription detected by BrUTP incorporation (c) are observed in a
metaphase HeLa cell (a) on the DAPI-stained chromosomes (b)
aligned at the metaphase plate as shown by superimposition of
the phase-contrast image, DAPI staining, and in situ transcrip-
tion detection (d). Bar, 10 mm.The Journal of Cell Biology, Volume 148, 2000 270
kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527–536.
Moore, G.P.M., and N.R. Ringertz. 1973. Localization of DNA-dependent
RNA polymerase activities in fixed human fibroblasts by autoradiography.
Exp. Cell Res. 76:223–228.
Moss, T., and V.Y. Stefanovsky. 1995. Promotion and regulation of ribosomal
transcription in eukaryotes by RNA polymerase I. Prog. Nucl. Acid Res.
Mol. Biol. 50:25–65.
Paulson, J.R., J.S. Patzlaff, and A.J. Vallis. 1996. Evidence that the endogenous
histone H1 phosphatase in HeLa mitotic chromosomes is protein phos-
phatase 1, not protein phosphatase 2A. J. Cell Sci. 109:1437–1447.
Prescott, D.M., and M.A. Bender. 1962. Synthesis of RNA and protein during
mitosis in mammalian tissue culture cells. Exp. Cell Res. 26:260–268.
Roussel, P., C. André, C. Masson, G. Géraud, and D. Hernandez-Verdun. 1993.
Localization of the RNA polymerase I transcription factor hUBF during the
cell cycle. J. Cell Sci. 104:327–337.
Roussel, P., C. André, L. Comai, and D. Hernandez-Verdun. 1996. The rDNA
transcription machinery is assembled during mitosis in active NORs and ab-
sent in inactive NORs. J. Cell Biol. 133:235–246.
Sander, E.E., and I. Grummt. 1997. Oligomerization of the transcription termi-
nation factor TTF-1: implications for the structural organization of riboso-
mal transcription units. Nucleic Acids Res. 25:1142–1147.
Savino, T.M., R. Bastos, E. Jansen, and D. Hernandez-Verdun. 1999. The nu-
cleolar antigen Nop52, the human homologue of the yeast ribosomal RNA
processing RRP1, is recruited at late stages of nucleologenesis. J. Cell Sci.
112:1889–1900.
Segil, N., M. Guermah, A. Hoffmann, R.G. Roeder, and N. Heintz. 1996. Mi-
totic regulation of TFIID: inhibition of activator-dependent transcription
and changes in subcellular localization. Genes Dev. 10:2389–2400.
Sirri, V., P. Roussel, and D. Hernandez-Verdun. 1999. The mitotically phos-
phorylated form of the transcription termination factor TTF-1 is associated
with the repressed rDNA transcription machinery. J. Cell Sci. 112:3259–
3268.
Thiry, M., and G. Goessens. 1996. The Nucleolus during the Cell Cycle.
Springer-Verlag, Heidelberg. 146 pp.
Weisenberger, D., and U. Scheer. 1995. A possible mechanism for the inhibi-
tion of ribosomal RNA gene transcription during mitosis. J. Cell Biol. 129:
561–575.
Westendorf, J.M., K.N. Konstantinov, S. Wormsley, M.-D. Shu, N. Matsumoto-
Taniura, F. Pirollet, F.G. Klier, L. Gerace, and S.J. Baserga. 1998. M phase
phosphoprotein 10 is a human U3 small nucleolar ribonucleoprotein compo-
nent. Mol. Biol. Cell. 9:437–449.
White, R.J., T.M. Goettlieb, C.S. Downes, and S.P. Jackson. 1995. Mitotic regu-
lation of a TaTa-binding-protein-containing complex. Mol. Cell. Biol. 15:
1983–1992.
Wilson, G.N., L.L. Szura, C. Rushford, D. Jackson, and J. Erickson. 1982.
Structure and variation of human ribosomal DNA: the external transcribed
spacer and adjacent regions. Am. J. Hum. Genet. 34:32–49.
Zatsepina, O.V., R. Voit, I. Grummt, H. Spring, M.V. Semenov, and M.F. Tren-
delenburg. 1993. The RNA polymerase I-specific transcription initiation fac-
tor UBF is associated with transcriptionally active and inactive ribosomal
genes. Chromosoma. 102:599–611.